Home > Browse Issues > Vol.37 No.8

The Optimization of H&E and LFB Staining Technique of Frozen Sections and Its Application in Autoimmune Diseases


Qin Chaoyan1, Wang Tingting1, Shi Changjie1, Du Changsheng1,2*
1Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology,Tongji University, Shanghai 200092, China;
2State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica,Chinese Academy of Sciences, Shanghai 201203, China
Abstract: This study was designed to investigate the optimization of hematoxylin-eosin (H&E) staining and luxol fast blue (LFB) staining in the frozen sections and application of histopathological analysis in experimental autoimmune encephalomyelitis (EAE). Five spinal cord samples were prepared from normal C57BL/6 mice and EAE mice, and each of the sample was divided into two halves for frozen embedding and paraffin embedding relatively.In the optimized conditions, results of the H&E staining and LFB staining between frozen sections and paraffin sections were compared. In paraffin sections, a fine morphology and structure of the cells were observed in H&E and LFB staining. In frozen sections, the clarity of the cells structure which was stained by H&E and LFB was almost identical with paraffin sections. The methods of H&E and LFB staining based on frozen sections were further applied to analyze the pathological changes in EAE model, and found it could repeat the known phenomena that β-arrestin2 knockout reduced EAE pathogenesis. After optimizing, staining methods based on frozen sections can achieve a similar fine performance to paraffin sections. In addition, the procedure of frozen sections production was simple and fast.Furthermore, the staining was more time-saving efficient than paraffin sections. The optimizing methods were also could be preferably applied to analyze pathological changes of autoimmune disease, which would have a wide range of applications in the study of autoimmune diseases, especially in an animal model of multiple sclerosis.


CSTR: 32200.14.cjcb.2015.08.0011